Katrina Megget

Conference
Questions, dilemmas abound in fast-moving world of trauma imaging
Time is of the essence when it comes to polytrauma, yet numerous questions arise about how and who should be scanned and for which conditions. For a trauma team, making the right imaging decisions for patients with severe injuries can be complex and a matter of life and death. Trauma specialists shared their experiences at today's session at ECR 2018.
March 3, 2018
2018 03 03 21 33 6946 2018 03 04 Polytrauma2 Thumb
Conference
Necessity of gadolinium contrast comes under scrutiny
Gadolinium-enhanced MRI scans have been the gold standard in suspected cases of vestibular schwannoma and multiple sclerosis (MS), but given the growing evidence of deposits left in the brain, debate has ensued about how to image wisely. Is it always necessary to use gadolinium contrast agents? Regarding vestibular schwannoma and MS, today's Pros and Cons Session will explore this question.
March 1, 2018
2018 03 02 06 07 8916 2018 03 02 Gadolinium2 20180302062418
Conference
Safety issues linger over gadolinium-based contrast agents
Conclusive research into the safety of gadolinium-based contrast agents could take about a decade to emerge because of the huge difficulties of obtaining enough valuable and objective data. In the meantime, radiologists will be dependent on newly released guidelines from the world's health watchdogs and other reports, ECR 2018 delegates will learn at today's Special Focus Session.
February 27, 2018
2018 02 27 00 16 3594 2018 02 28 Gadolinium 20180227001452
Conference
To be or not to be alarmed over gadolinium contrast? That is the question
The medical imaging community should be neither alarmed nor develop a gadolinium phobia while waiting for guidance from regulators over controversial gadolinium contrast agents. This is the opinion of Dr. Howard Rowley from the University of Wisconsin in the U.S. and president of the American Society of Neuroradiology.
March 2, 2017
2017 03 02 17 51 10 177 2017 03 03 Gadolinium Thumb 20170303005132
Conference
Cost-effectiveness, implementation still hinder lung cancer screening
The public desire for lung cancer screening and the ability of the medical profession to implement it are currently at odds, despite recent findings that suggest screening via low-dose CT can reduce mortality. The problem is lung cancer screening remains controversial and is not as straightforward as most people think, according to Dr. Stefan Diederich, PhD.
March 1, 2017
2017 03 01 15 23 43 165 Sa5 Lung Cancer Screening Image 20170301222409
Page 1 of 1
Top Stories
Student Doctor Laptop Test 400
Radiology Education
Sectra to supply education platform to four Danish facilities
Sectra is to provide its platform for medical education, Sectra Education Portal, to four university hospital in Denmark.
Euros Bills
Artificial Intelligence
Median posts Q1 results, reports net loss for 2023
Pieter Kroese Ceo Screen Point Medical
Womens Imaging
ScreenPoint CEO steps down; new CEO named
Euros Bills
Ultrasound
Esaote reports growth in fiscal year 2023
Register today for a FREE webinar 8 May at 6 p.m. CET
Sponsor Content
Register today for a FREE webinar 8 May at 6 p.m. CET
More in Home
Sectra to supply education platform to four Danish facilities
By AuntMinnieEurope.com staff writers
Sectra is to provide its platform for medical education, Sectra Education Portal, to four university hospital in Denmark.
April 26, 2024
Student Doctor Laptop Test 400
Median posts Q1 results, reports net loss for 2023
By AuntMinnieEurope.com staff writers
France-based Median Technologies recently reported its financial results for the first quarter of the 2024 fiscal year.
April 26, 2024
Euros Bills
ScreenPoint CEO steps down; new CEO named
By AuntMinnieEurope.com staff writers
ScreenPoint Medical CEO Mark Koeniguer is stepping down from his position, with Pieter Kroese being named his successor.
April 26, 2024
Pieter Kroese Ceo Screen Point Medical
Esaote reports growth in fiscal year 2023
By AuntMinnieEurope.com staff writers
Italian medical device vendor Esaote posted increased revenues for fiscal year 2023, citing upticks in sales in its ultrasound and MRI sectors.
April 25, 2024
Euros Bills
Smart Reporting secures €23M in financing
By AuntMinnie.com staff writers
Munich-based AI software company Smart Reporting has announced it has finalized a funding deal worth €23 million.
April 25, 2024
Euros
EUCAIM calls for new applicants and prepares for webinar
By AuntMinnie.com staff writers
The European Federation for Cancer Images (EUCAIM) has launched an open call for new applicants and announced a webinar to provide insights into the process.
April 25, 2024
Euro Flag
First patient dosed with ITM-31 in glioblastoma trial
By AuntMinnieEurope.com staff writers
The University Hospital MĂĽnster, Helmholtz Munich, and ITM have announced that the first patient has been dosed in a glioblastoma trial with ITM-31.
April 23, 2024
Radiotherapy 400 (1)
ESR releases movie to mark key moments of ECR 2024
By AuntMinnieEurope.com staff writers
The European Society of Radiology (ESR) has produced a short movie to celebrate the most memorable moments and events at ECR 2024.
April 23, 2024
Screenshot (1151)
MRI-guided HIFU improves treatment of essential tremor, Parkinson’s
By AuntMinnieEurope.com staff writers
MRI-guided high-intensity focused ultrasound (HIFU) has improved treatment of essential tremor and Parkinson's disease, according to the Spanish Society of Medical Radiology (SERAM).
April 22, 2024
Parkinsons Hand Shaking
EC recommendation pushes clinical audits of medical radiological practices
By AuntMinnieEurope.com staff writers
The European Commission (EC) has adopted a recommendation that will drive regulations and clinical audits of medical radiological practices throughout member states.
April 19, 2024
Audit 400
Accuray opens training facility in Switzerland
By AuntMinnieEurope.com staff writers
Accuray has opened a new training center in Genolier, Switzerland.
April 19, 2024
Accuray Astro 2019
Raigmore Hospital in Scotland selects RayCare
By AuntMinnieEurope.com staff writers
Radiation therapy software developer RaySearch Laboratories said that its RayCare oncology information system will be deployed at Raigmore Hospital in Inverness, Scotland.
April 17, 2024
Ray Search
Page 1 of 13
Next Page